Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Revaccination, H4:IC31, and H56:IC31 in Healthy Adolescents
NCT02378207Phase 1Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of H4:IC31 and AERAS-456 in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started May 2015; status: completed.
02
Drugs
H4:IC31AERAS-456
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02378207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378207.